000 | 01895 a2200517 4500 | ||
---|---|---|---|
005 | 20250515230436.0 | ||
264 | 0 | _c20101206 | |
008 | 201012s 0 0 eng d | ||
022 | _a1097-4547 | ||
024 | 7 |
_a10.1002/jnr.22448 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Peiwen | |
245 | 0 | 0 |
_aModulation of sensory neuron-specific receptors in the development of morphine tolerance and its neurochemical mechanisms. _h[electronic resource] |
260 |
_bJournal of neuroscience research _cOct 2010 |
||
300 |
_a2952-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aDrug Tolerance _xphysiology |
650 | 0 | 4 |
_aGanglia, Spinal _xcytology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanocyte-Stimulating Hormones _xpharmacology |
650 | 0 | 4 |
_aMorphine _xadverse effects |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 |
_aPain Measurement _xmethods |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
650 | 0 | 4 |
_aProtein Precursors _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSensory Receptor Cells _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
700 | 1 | _aWang, Dongmei | |
700 | 1 | _aLi, Meili | |
700 | 1 | _aZhang, Yanding | |
700 | 1 | _aQuirion, Rémi | |
700 | 1 | _aHong, Yanguo | |
773 | 0 |
_tJournal of neuroscience research _gvol. 88 _gno. 13 _gp. 2952-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jnr.22448 _zAvailable from publisher's website |
999 |
_c19916824 _d19916824 |